oxfordscienceenterprises.com ↗Activity from announced rounds
Venture building and investment across Oxford’s deep tech, life sciences and health technology ecosystem.
Oxford Science Enterprises builds and funds companies from Oxford’s science ecosystem. It works with university researchers, technology hubs and independent scientific startups, combining company formation with investment from pre-seed through growth. Its stated sectors are deep tech, life sciences and health technology.
Covered financings include Vivid Dx in diagnostics, Mirae in chronic care, ReEmerge in brain-injury rehabilitation, MCatalysis in fuels and events involving Oxford Quantum Circuits and Quantum Motion. These illustrate the range of recorded scientific businesses; OSE’s own directory describes its broader portfolio.
ReEmerge is developing Cognitive Network Restoration Therapy (CNRT) for people with chronic cognitive impairment after brain injury. The treatment targets underactive but viable neural circuits in the central thalamus to restore function across disrupted brain networks; the company is advancing this restorative approach through clinical development.
Causal AI and pharmaceutical development services for reformulating complex drugs and directing laboratory studies.